• Regentis recently received European regulatory approval for a next-generation GelrinC manufacturing process that increases production yield by 400%.
• The company is advancing commercialization through scalable manufacturing, surgeon training programs, and continued U.S. Phase III clinical progress.
• These developments reinforce Regentis’ strategy of bringing innovative cartilage repair technology from clinical validation to commercial scale, with unit economics that improve as production volumes build.

Regentis Biomaterials Ltd. (NYSE American: RGNT) is advancing GelrinC, its innovative cell-free hydrogel implant for focal knee cartilage repair, with a value proposition that extends across the entire healthcare ecosystem. Designed to simplify treatment while improving clinical outcomes, GelrinC offers meaningful benefits for surgeons, patients, and healthcare payers alike. Recent European regulatory approval for a next-generation solvent-free manufacturing process, which boosts production yield by approximately 400%, strengthens the company’s ability to deliver a practical, scalable solution that addresses longstanding limitations in cartilage repair at a much lower production cost.

Unlike complex cell-based therapies or temporary treatment approaches such as microfracture, GelrinC is designed as an off-the-shelf solution. The ready-to-use hydrogel is delivered during a single procedure lasting roughly 10 minutes, cures in situ, and gradually resorbs as the patient’s own cells regenerate durable, hyaline-like cartilage. This combination of procedural simplicity, clinical performance, and favorable economics creates a compelling value proposition for surgeons, patients, and healthcare payers.

The Surgeon Win: Seamless Integration and Procedural Simplicity

Orthopedic surgeons face constant pressure to deliver better outcomes within tight operating room schedules and existing workflows. GelrinC is designed to integrate easily into these orthopedic processes The minimally invasive, single-step procedure takes roughly 10 minutes and requires no cell harvesting, laboratory processing, or staged surgeries.

This streamlined approach fits naturally into the standard surgeon workflows, helping reduce operative complexity compared with many current treatment approaches. With faster ~2-week recovery times (versus 6 weeks or more for some treatments), surgeons can offer patients a more efficient path back to function. Regentis is further supporting adoption through surgeon training programs and European Centers of Excellence, including collaborations with leading institutions such as Humanitas Research Hospital in Milan, Italy.

The Patient Win: Better Outcomes and Faster Return to Life

For patients with focal knee cartilage injuries, durable repair is often more valuable than temporary symptom relief. Clinical data from GelrinC studies show approximately 100% greater improvement in pain and function scores versus microfracture at two years, with MRI evidence of near-native cartilage regeneration and sustained benefits over multiple years.

The shorter recovery period and potential for durable repair translate into quicker returns to work, sports, and daily activities, addressing one of the most frustrating aspects of traditional cartilage treatments.

The Payer Win: Cost-Effectiveness and Value-Based Care

As healthcare systems continue shifting toward value-based care, payers are placing greater emphasis on treatments that improve outcomes while lowering total costs of care. GelrinC aligns well with this shift. As an off-the-shelf product, it avoids the high expenses associated with personalized cell therapies and is expected to the current estimated at $40,000+ cost of cell-based products to one-fourth–~$10,000, while maintaining very strong gross margins. Its shorter 10-minute procedure time, faster patient recovery, and potential to reduce repeat interventions have the potential to improve the overall economic value of treatment for insurers and healthcare systems.

These advantages are especially timely as the U.S. cartilage repair market, estimated at ~$3 billion and encompassing roughly 470,000 annual procedures, continues to grow amid aging populations and rising sports injuries.

Building Commercial Momentum

Regentis is executing on multiple fronts to turn clinical promise into commercial reality. The newly approved solvent-free process lifts production yield by roughly 400% while improving manufacturing efficiency and lowering production costs—important milestones as the company prepares for broader European commercialization.

In the United States, the company continues to advance its pivotal Phase III SAGE trial, which is already over 50% enrolled, under an FDA-approved protocol, and expect to complete enrollment in 2026, while preparing for Premarket Approval (“PMA”) submission. With CE Mark approval already in hand for Europe, these developments position Regentis to potentially establish GelrinC as the first true off-the-shelf regenerative solution in a market that has long lacked practical, durable options.

Why GelrinC Could Become the Standard of Care

By addressing practical challenges related to surgical workflow, clinical durability, and healthcare economics, GelrinC represents more than an incremental advance in cartilage repair. For investors, the case rests on the same economics: off-the-shelf scalability and a lower production cost base, applied to a U.S. cartilage repair market of roughly 470,000 annual procedures and an estimated $3 billion. The company’s continued progress in manufacturing, physician education, and late-stage clinical development demonstrates a deliberate strategy focused on commercial execution as well as clinical innovation.

As current clinical and commercialization milestones continue to build, GelrinC has the potential to reshape the treatment landscape for focal knee cartilage injuries by offering a solution that better aligns the interests of physicians, patients, healthcare systems, and the investors backing them.

This content has been disseminated on behalf of Regentis Biomaterials Ltd. (NASDAQ: RGNT) as part of a paid investor awareness and marketing engagement.

NOTE TO INVESTORS: The latest news and updates relating to RGNT are available in the company’s newsroom at https//ibn.fm/RGNT

• A key acquisition brought in the Skaergaard project, a palladium, gold and platinum deposit in southeast Greenland now held through the company’s subsidiary Major Precious Greenland A/S.
• Additional acquisitions, including a rare earths asset, represent the company’s focus on becoming a significant player in the mining space.

A company can rarely reinvent itself overnight, but  Greenland Mines (NASDAQ: GRML), has come close. What started the year as a biotech firm has become a two-division mining company in the span of a few months, and its acquisition activity since then shows no sign of slowing.

Previously known as Klotho Neurosciences Inc., the company traded under the ticker KLTO. In March 2026, however, the company announced two significant changes: a name change to Greenland Mines Ltd and a NASDAQ ticker switch to GRML. In addition, the announcement noted a strategic acquisition that shifted the company’s core focus. The filing was announced through an 8-K with the Securities and Exchange Commission, along with an investor webcast explaining the move to shareholders.

That acquisition brought in the Skaergaard project, a palladium, gold and platinum deposit in southeast Greenland now held through the company’s subsidiary Major Precious Greenland A/S. Since March, the company has continued building momentum. Last month, Greenland reported an updated mineral resource estimate under the SEC’s S-K 1300 standard, raising indicated palladium equivalent metal by 31% to 15.0 million ounces and lifting the indicated grade by 36% to 3.04 grams per tonne.

Earlier, in May, the company signed a definitive agreement to acquire the Sarfartoq neodymium-praseodymium rare earths project from Neo Performance Materials for $35 million, split between $20 million in cash and $15 million in company stock. Sarfartoq’s historic resource includes an estimated 27 million kilograms of neodymium oxide and 8 million kilograms of praseodymium oxide, elements used in the permanent magnets that power electric vehicles and wind turbines. 

Neo Performance Materials is staying involved rather than exiting. The company is retaining an equity stake in Greenland Mines along with offtake rights covering up to 60% of Sarfartoq’s future production once the acquisition closes, effectively lining up a buyer before the project reaches production. Closing remains subject to approval from the Greenland government under the country’s Mineral Activities Act.

The company added a third leg to its strategy in June 2026 through a share exchange agreement with AnorTech Inc., a company trading on the TSX Venture Exchange. Greenland Mines agreed to acquire a 9.9% equity stake in AnorTech for roughly C$5 million, paid in newly issued Greenland Mines shares, with an option to increase its position to as much as 19.9% during the following six months. The deal gives Greenland Mines exposure to sustainable and high-purity alumina production, adding a processing layer above its upstream mining assets.

Notably, the company has not abandoned its biotech roots. Its cell and gene therapy division continues to advance KLTO-202, targeting amyotrophic lateral sclerosis, along with KLTO-101, aimed at Alzheimer’s disease, and additional therapies for Parkinson’s and other age-related disorders. That keeps Greenland Mines as a company with exposure to both natural resources and biotechnology under one publicly traded structure, an unusual combination for a NASDAQ-listed exploration company.

Taken together, the moves since March 2026 show a company moving quickly to build out a broader platform. A name change and ticker switch brought in a flagship precious metals project, a resource upgrade strengthened that project’s regulatory standing, a rare earths acquisition added a second critical mineral exposure with a committed offtake partner and an equity investment added downstream materials optionality. 

For more information, visit www.GreenlandMines.com.

NOTE TO INVESTORS: The latest news and updates relating to GRML are available in the company’s newsroom at https://ibn.fm/GRML

• The company presented its Texatron(TM) Fusion Engine(TM) development program and related scientific research at the American Physical Society Division of Particles and Fields 2026 Meeting held at Fermilab.
• Chief Technology Officer Dr. John E. Brandenburg outlined the company’s Texatron(TM) development efforts alongside his Gravity-Electromagnetic (“GEM”) Unification Theory.
• The company continues to develop the Texatron(TM) Fusion Engine(TM) through its wholly owned subsidiary, Kepler Fusion Technologies, with a focus on modular fusion energy systems.
• American Fusion(TM) believes the theoretical plasma physics concepts presented may complement the ongoing engineering development of the Texatron(TM) platform, although the GEM theory remains subject to continued scientific evaluation.

American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies, has taken another step in advancing the visibility of its fusion energy research, with Chief Technology Officer Dr. John E. Brandenburg presenting the company’s Texatron(TM) Fusion Engine(TM) development program during one of the leading scientific conferences for particle physics.

The presentation took place at the American Physical Society (“APS”) Division of Particles and Fields (“DPF”) 2026 Meeting, hosted at the U.S. Department of Energy’s Fermi National Accelerator Laboratory (“Fermilab”) in Batavia, Illinois. The biennial conference brings together researchers from national laboratories, universities, and research institutions, to discuss developments in particle physics and related fields (https://ibn.fm/lsPyu). 

Alongside an introductory overview of the Texatron(TM) Fusion Engine(TM) program, Dr. Brandenburg presented his Gravity-Electromagnetic (“GEM”) Unification Theory, a theoretical framework that proposes a first-principles mathematical derivation of Newton’s gravitational constant. According to the company, the presentation explored how gravity, electromagnetism, plasma physics, and quantum mechanics, may all be connected within a unified analytical framework.

The GEM theory proposes that Newton’s gravitational constant is not simply an experimentally measured value but emerges from the physical conditions believed to have existed in the early universe. The presentation also discussed the incorporation of quantum mechanics into the model through the fine-structure constant and examined mathematical relationships associated with hydrogen plasma.

While the GEM framework remains a theoretical model requiring continued scientific evaluation, American Fusion(TM) said it believes aspects of the plasma physics discussed could complement future theoretical work supporting the engineering development of the Texatron(TM) Fusion Engine(TM). The company emphasized that its fusion program continues to be driven by experimental validation and ongoing research.

According to the company, the presentation generated substantial audience participation, with attendees posing technical questions regarding the GEM framework and its underlying assumptions. Management characterized the discussion as part of its broader commitment to scientific dialogue and peer engagement as development of the Texatron(TM) platform continues.

“Presenting the Texatron(TM) development program and Dr. Brandenburg’s GEM Unification Theory before one of the world’s premier particle physics communities reflects our commitment to advancing scientific dialogue through rigorous analysis, constructive technical discussion, experimental validation, and peer engagement,” commented Executive Chairman Brent Nelson. “We congratulate Dr. Brandenburg on an outstanding presentation and look forward to continuing our research and development efforts as the Texatron(TM) program advances.”

American Fusion(TM) is developing its fusion technology through its wholly owned subsidiary, Kepler Fusion Technologies. Unlike conventional large-scale fusion concepts requiring centralized facilities, the Texatron(TM) Fusion Engine(TM) is being designed as a modular platform capable of deployment across multiple end markets. Management has previously outlined commercial opportunities that include data centers, industrial facilities, mining operations, defense applications and locations where electric grid capacity is constrained.

The company has also continued expanding its intellectual property portfolio as development progresses. Earlier this year, American Fusion(TM) announced additional U.S. patent filings covering various aspects of the Texatron(TM) platform, reflecting a strategy that combines engineering development with long-term protection of proprietary technologies.

Operationally, the company has continued advancing its testing program during 2026. Previous announcements described regulatory approvals supporting testing activities in Texas and outlined plans to evaluate multiple Texatron(TM) system configurations spanning power outputs from hundreds of kilowatts to multi-megawatt installations. Management has indicated that these efforts are intended to generate engineering data supporting future commercialization.

For more information, visit the company’s website at www.AmericanFusionEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to AMFN are available in the company’s newsroom at https://ibn.fm/AMFN

• The company has advanced its VXA-222 bispecific antibody-drug conjugate (“bsADC”) program into the next stage of development following completion of the discovery phase with OmniAb.
• OmniAb delivered a portfolio of therapeutic antibody binders, with VERAXA now responsible for engineering the final bispecific ADC candidate and advancing preclinical validation.
• Although VXA-222 is not based on VERAXA’s BiTAC platform, it leverages the company’s proprietary antibody engineering, linker and conjugation technologies and represents one of its more advanced development programs.
• VERAXA recently expanded its intellectual property portfolio with its first BiTAC-related patent filings alongside additional patents supporting conjugation chemistry, payloads and antibody technologies.
• The company now holds more than 50 granted owned or exclusively licensed patents across 26 patent families in 14 countries, with newly filed applications expected to extend protection into at least 2047.
• VERAXA continues building a diversified oncology pipeline spanning bispecific antibody-drug conjugates, T-cell engagers, and engineered antibody formats targeting difficult-to-treat cancers.

VERAXA (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has reached another development milestone in its oncology pipeline, announcing that its VXA-222 bispecific antibody-drug conjugate (“bsADC”) program has advanced beyond the discovery phase and into the next stage of development. The milestone reflects continued progress across the company’s therapeutic portfolio as it simultaneously expands the intellectual property supporting its next generation of antibody-based cancer therapies.

The announcement marks the successful completion of the discovery portion of VERAXA’s collaboration with OmniAb Inc., which began in May 2025 (https://ibn.fm/PBtmc). With the discovery work completed, VERAXA will now focus on building the final therapeutic candidate by combining the antibody binders identified through the collaboration with its own antibody engineering, linker and conjugation technologies. The company will also conduct the in vitro and in vivo validation required before further development.

The VXA-222 program is designed as a bispecific antibody-drug conjugate that uses an “AND-gate” approach to recognize two separate tumor-associated antigens simultaneously. By requiring both targets to be present before delivering its therapeutic payload, the approach is intended to improve tumor selectivity while limiting exposure to healthy tissue.

The collaboration combined complementary capabilities from both companies. OmniAb contributed its antibody discovery platform, including its OmniClic(TM) transgenic chicken technology, which is designed to generate common light-chain antibodies suitable for bispecific therapeutics. Those technologies produced a diverse collection of human antibody candidates optimized through in vivo affinity maturation.

VERAXA now assumes responsibility for transforming those antibody binders into a final therapeutic candidate. The company will apply its proprietary linker technology and conjugation methods to create the finished bispecific antibody-drug conjugate before advancing the program through preclinical evaluation.

Although VXA-222 is not built on VERAXA’s newest BiTAC technology platform, the program illustrates another dimension of the company’s development strategy. Management views VXA-222 as one of its more advanced antibody-drug conjugate programs while continuing to apply the engineering and conjugation expertise developed across its broader technology portfolio.

The company retains exclusive rights to develop and commercialize products arising from the collaboration, while OmniAb is entitled to receive a share of specified future revenues generated by products incorporating the antibodies identified through the partnership.

The latest pipeline progress comes as antibody-drug conjugates continue attracting significant investment across the biotechnology sector. These therapies combine the targeting capability of monoclonal antibodies with highly potent anti-cancer payloads, allowing drugs to be delivered more selectively to tumor cells. Bispecific formats seek to further improve precision by recognizing multiple biological targets simultaneously.

Alongside its pipeline progress, VERAXA recently provided investors with an update on another asset often viewed as equally important for emerging biotechnology companies: its intellectual property portfolio. In a separate announcement issued on July 29, the company disclosed that it had filed its first patent applications covering its newest BiTAC technology platforms, including both BiTAC-TCE and BiTAC-ADC therapeutic programs (https://ibn.fm/Fkn1I).

The new filings extend beyond individual product candidates. They encompass composition-of-matter claims, proprietary payload technologies and innovations supporting the company’s broader antibody engineering platform. Additional patents covering enabling technologies, including click chemistry and conjugation methods, have also completed their opposition periods, further strengthening the company’s intellectual property position.

According to VERAXA, the company now controls a portfolio of more than 50 granted owned or exclusively licensed patents spanning 26 patent families across 14 countries. If the recently submitted applications are ultimately granted, protection for portions of the company’s core technology suite is expected to extend through at least 2047.

The patent activity also highlights the breadth of VERAXA’s research efforts. Rather than concentrating exclusively on individual therapeutic candidates, the company is pursuing innovations across multiple components of antibody therapeutics, including molecular formats, mechanisms of action, linker chemistry, payload technologies and manufacturing approaches.

Much of that work centers on the company’s proprietary BiTAC platform, which is designed to improve tumor selectivity through dual-component molecular architectures. Unlike conventional antibody therapies that rely on a single binding event, BiTAC approaches require simultaneous recognition of two tumor-associated targets before therapeutic activity is activated.

For BiTAC-T cell engagers, this involves two separate antibody constructs that assemble into an active molecule only after binding to the same cancer cell. Within the BiTAC-ADC platform, two antibodies independently deliver inactive components that become therapeutically active only after undergoing a highly specific click-to-release chemical reaction inside targeted tumor cells.

Management believes these approaches may improve safety by reducing activity in healthy tissues while also addressing some manufacturing and stability limitations associated with earlier antibody-drug conjugate technologies.

Beyond BiTAC, VERAXA continues developing a diversified oncology pipeline that includes conventional and bispecific antibody-drug conjugates, engineered antibody formats and additional antibody-based therapeutics. Together with programs such as VXA-222, the expanding patent portfolio reflects a strategy that combines product development with continued investment in the underlying technologies supporting future candidates.

For more information, visit the company’s website at www.Veraxa.com.

NOTE TO INVESTORS: The latest news and updates relating to VRXA are available in the company’s newsroom at https://ibn.fm/VRXA

• TechForce Robotics deploys AI-powered service robots that automate operational tasks across hospitality, pharmaceutical, laboratory, and industrial environments
• BIM-E, TIM-E, and LIM-E are designed to improve labor efficiency, operational consistency, and scalability rather than serve as novelty attractions
• The company’s expanding robotics ecosystem aligns with growing enterprise demand for automation solutions that deliver measurable business value and return on investment

Not long ago, service robots were largely regarded as attention-grabbing tools, used to create outstanding customer experiences but offering little in terms of operations. Today, that perception is quickly changing. As persistent labor shortages, rising operational costs, and increased demand for efficiency reshape industries globally, businesses are increasingly evaluating robotics based on measuring outcomes, including productivity gains, workforce optimization, cost savings, and return on investment (ibn.fm/KK2Gw).

Nightfood Holdings (OTCQB: NGTF), operating under the name TechForce Robotics, is strategically positioning itself at the nexus of this evolution by developing AI-driven automation solutions that perform practical, repeatable operations tasks across pharmaceutical, hospitality, laboratory, and industrial environments. Rather than building robots designed mainly to entertain, the company is focused on technologies that assist organizations in improving operational performance while reducing dependence on manual labor.

The company’s growing portfolio, including BIM-E, TIM-E and LIM-E, underscore this shift toward customized automation. Rather than serving as customer attractions, these platforms are designed to automate routine operational workflows, improve service consistency and allow employees to focus on higher-value responsibilities.

The rapid expansion of artificial intelligence infrastructure is fueling investment across the broader technology ecosystem, creating ripple effects that extend well beyond data centers and cloud computing. As semiconductor manufacturers, AI hardware providers and enterprise technology companies continue scaling the infrastructure needed to support sophisticated AI models, commercial robotics developers are gaining access to more capable processing power, improved AI functionality and a mature technology stack. These advancements are accelerating the deployment of intelligent robotic systems capable of performing real-world tasks with greater autonomy, reliability and precision.

Through TechForce Robotics, the company is making inroads into laboratory automation, pharmaceutical manufacturing, and industrial applications, sectors where repeatability, precision, and operational efficiency are important. The company’s recently announced partnership with Jiun Jiang (“JJ Enterprise”) to advance AI infrastructure, semiconductor manufacturing automation and pharmaceutical robotics illustrates its commitment to engage in some of today’s fastest-growing technology sectors while broadening its commercial opportunities.

This diversified approach reflects a larger transformation taking place throughout enterprise automation. Rather than deploying isolated robotic solutions to solve individual problems, organizations are investing in integrated AI-enabled platforms capable of improving productivity across multiple operational functions. Companies that can offer adaptable automation technologies spanning several industries may be well positioned as enterprise adoption continues to accelerate.

For investors, the conversation surrounding service robotics is evolving from technological novelty to commercial execution. The key question is no longer whether autonomous systems can perform useful tasks, but whether they can consistently improve operational performance while generating measurable returns. Through TechForce Robotics, Nightfood Holdings is building its strategy around that shift, combining AI-powered automation, an expanding robotics portfolio and targeted acquisitions to position itself alongside the growing enterprise demand for scalable, ROI-driven automation solutions.

For more information, visit the company’s website at TechForceRobotics.com.

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at https://ibn.fm/NGTF

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

• Powermax recently commenced its 2026 exploration program at its Cameron REE Project, building on encouraging results from previous exploration and intended to guide the company’s next phase of exploration
• The program is designed to integrate geological mapping, geochemical sampling, and targeted geophysical surveys, to better define and prioritize exploration targets
• The company’s earlier exploration at the property revealed consistent enrichment of both light and heavy rare earth elements across multiple lithological units
• The three-week field program has been designed to follow up encouraging results from previous stream sediment, soil, and rock geochemical surveys

Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF), a Canadian mineral exploration company, recently announced that it had commenced its 2026 exploration program at its 100%-owned Cameron Rare Earth Element (“REE”) project located in the Kamloops Mining Division of British Columbia. The three-week program is a follow-up to the encouraging results from previous stream sediment, soil, and rock geochemical surveys, which were conducted as part of the company’s Phase 2 exploration program at the property (https://ibn.fm/We2oM).

The 2026 exploration program will be conducted using road-supported access and limited, supplementary helicopter support where necessary. It will include detailed geological mapping and prospecting, selective rock sampling, infill soil sampling, additional stream sediment sampling, ground radiometric sampling, and the integration of datasets into a comprehensive target ranking model to support future trenching and first-pass drill planning.

This program aims to refine the location and continuity of previously identified REE target corridors; better define potential bedrock sources responsible for anomalous stream sediments and soil geochemistry; improve geological understanding of pegmatite-hosted REE mineralization; and integrate geological, geochemical, and radiometric information to prioritize targets for follow-up trenching and drill testing.

“We are pleased to commence this important 2026 exploration program at the Cameron REE Project. Building on encouraging results from previous exploration, this program has been designed to integrate geological mapping, geochemical sampling and targeted geophysical surveys to better define and prioritize exploration targets. We look forward to completing the program and using the results to guide the next phase of exploration,” commented Paul Gorman, CEO of Powermax Minerals.

The Cameron REE Property is a 2,984-hectare project located strategically within a tier-1 mining jurisdiction. It boasts world-class infrastructure, with Canada’s Highway 23 traversing the property and connecting to the Trans-Canada Highway 1 30 kilometers to the north. The project contains three contiguous mining claims whose historic exploration shows potential REE, niobium, and other mineralization. 

Phase 1 and Phase 2 Exploration Programs

Powermax Minerals completed its Phase 1 exploration, which confirmed the presence of light rare earth element (“LREE”) and heavy rare earth element (“HREE”) mineralization across the property. The Phase 1 results showed total REE (“TREE”) values ranging from 17 ppm to 1,943 ppm, while the heavy mineral concentrates samples had TREE values ranging from 365 ppm to 7,561 ppm. The results also showed consistent enrichment of both LREEs and HREEs across multiple lithological units, with LREEs being more abundant than HREEs. 

These results encouraged the company to commence its Phase 2 exploration program in October 2025. The Phase 2 program’s objectives included geological mapping and systematic rock sampling, additional stream sediment and soil geochemical surveys, and the integration of geological, geochemical, and geophysical datasets in a GIS platform to refine and prioritize drill targets (https://ibn.fm/TAUzx).

The soil geochemical sampling program returned total rare earth oxide (“TREO”) values ranging between approximately 135 ppm and 2,840 ppm, while the surface rock samples returned TREO values ranging from 36 ppm to 740 ppm (https://ibn.fm/N9mva). Moreover, the results from the stream sediment sampling showed elevated light rare earth oxides (“LREOs”), heavy rare earth oxides (“HREOs”) and TREO (https://ibn.fm/n57E5). By completing these programs and reporting the results, the company is taking important steps to systematically advance the project, which could add significant value for its shareholders.

Exploration Target Cautionary Statement

The exploration targets discussed are conceptual, and there is currently not enough data to confirm a mineral resource. Further exploration may not yield successful results.

For more information, visit the company’s website at www.PowermaxMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to PWMXF are available in the company’s newsroom at https://ibn.fm/PWMXF

• AZIO AI is building an integrated technology infrastructure platform focused on AI data centers, enterprise GPU compute, high-performance computing and digital power solutions.
• In July 2026, the company completed its merger with AZIO AI Corporation and subsequently changed its corporate name and Nasdaq ticker symbol from EVTV to AZIO, completing its transformation into a dedicated AI infrastructure company.
• AZIO AI has announced a $27.9 million AI infrastructure and capacity agreement with Power Champion Investment Limited that is scalable to as much as $100 million as deployment expands. The company has reported receiving initial deposits under the agreement.
• The company recently executed a Master Services Agreement with AT&T to provide enterprise fiber connectivity for its planned 500-megawatt Texas AI infrastructure platform.
• Under the AT&T agreement, AZIO AI has committed approximately $2.4 million for high-capacity fiber services designed to support AI training, inference, GPU cloud computing, enterprise colocation and other high-performance computing workloads.
• AZIO AI has also reported entering into a Power Purchase and Hosting agreement with a GPU customer, supporting the need for an initial modular buildout at the company’s Texas site.
• The company’s business model encompasses AI data center development, GPU and server infrastructure sales and distribution, power hosting, compute leasing and strategic technology investments.
• AZIO AI’s strategy is designed to create multiple potential revenue channels across infrastructure development, equipment sales, hosting, power services and recurring compute capacity.
• The company is pursuing domestic and international opportunities serving enterprise, institutional, hyperscale and government-related customers.
• AZIO AI is positioning its Texas campus around scalable, energy-backed infrastructure intended to address rising demand for power-intensive AI and GPU computing workloads.

Azio AI Holdings (NASDAQ: AZIO) is a technology infrastructure company focused on developing, owning and operating artificial intelligence data centers, enterprise GPU compute infrastructure, high-performance computing systems, digital power solutions and digital asset mining operations.

The company is building an integrated AI infrastructure platform designed to serve enterprise, institutional, hyperscale and government-related customers across domestic and international markets. Its operating strategy encompasses the development of AI data center capacity, the sale and distribution of enterprise-grade GPU systems and server infrastructure, GPU cloud computing, power hosting, compute leasing and strategic technology investments.

In July 2026, the company completed its merger with AZIO AI Corporation. Following the transaction, the combined company adopted the AZIO AI Holdings name and began trading on the Nasdaq Capital Market under the ticker symbol “AZIO.” The rebranding aligned the company’s public-market identity with its strategic focus on AI infrastructure, GPU computing and energy-supported data center development.

Through this diversified strategy, AZIO AI is working to establish multiple potential revenue streams while addressing three of the most important requirements supporting the continued expansion of artificial intelligence: computing capacity, data center infrastructure and reliable power.

AI Data Center Development

AZIO AI is advancing the development of scalable AI data center infrastructure designed to support GPU-intensive computing workloads.

The company’s initial Texas platform is planned around a site with up to 500 megawatts of power availability. The campus is intended to support AI training and inference, GPU cloud computing, enterprise colocation, high-performance computing and other power-intensive technology applications.

The Texas location is situated in an area intended to accommodate large-scale industrial infrastructure, potentially reducing some of the land-use and community constraints encountered by data center projects located in densely populated urban markets.

AZIO AI’s development strategy emphasizes modular infrastructure that can be deployed incrementally as customer commitments, financing, power availability and construction milestones are achieved.

Enterprise Connectivity and AT&T Agreement

In July 2026, AZIO AI executed a Master Services Agreement with AT&T to provide enterprise fiber connectivity supporting the company’s planned 500-megawatt Texas AI infrastructure platform.

The agreement establishes a standardized connectivity framework intended to provide the high-capacity, low-latency network infrastructure required for AI training, inference, GPU cloud computing, enterprise colocation and high-performance computing workloads.

Under the agreement, AZIO AI has committed approximately $2.4 million for high-capacity fiber services. Management expects the framework to help streamline network deployment at the initial Texas campus and provide a repeatable operating model that could support future infrastructure expansion.

The fiber agreement represents an important development milestone because large-scale AI data centers require both substantial power capacity and reliable, high-bandwidth network connectivity to support customer workloads.

GPU Compute and Server Infrastructure

AZIO AI’s GPU compute business includes the sale and distribution of enterprise GPU systems, server racks and supporting infrastructure for customers deploying artificial intelligence and high-performance computing environments.

The company is pursuing commercial opportunities involving enterprise customers, data center operators, hyperscale platforms and international infrastructure programs. Its strategy combines infrastructure sourcing, system integration, deployment coordination and customer allocation management.

This segment is intended to generate equipment and infrastructure revenue while also supporting AZIO AI’s longer-term data center, hosting and recurring compute-capacity strategy.

Power Hosting and Compute Services

Power availability has become one of the principal constraints affecting the development of large-scale AI infrastructure. AZIO AI’s strategy therefore integrates data center development with digital power and hosting solutions.

The company has reported entering into a Power Purchase and Hosting agreement with a GPU customer that is expected to require an initial modular buildout at the Texas property. This commercial interest provides a potential foundation for phased development as AZIO AI advances site infrastructure and customer deployment planning.

Over time, the company intends to pursue revenue opportunities from power hosting, enterprise colocation, GPU cloud computing and compute leasing as its infrastructure becomes operational.

Power Champion Infrastructure Agreement

In July 2026, AZIO AI announced a $27.9 million AI infrastructure agreement with Power Champion Investment Limited. The agreement involves a capacity reservation that may scale to as much as $100 million as deployment expands.

AZIO AI has reported receiving initial deposits under the agreement, representing early commercial validation of its infrastructure pipeline. The agreement supports the company’s strategy of aligning infrastructure development with identifiable customer demand and staged deployment commitments.

The timing and ultimate value of any expanded deployment will depend on customer performance, financing, infrastructure availability and other customary commercial and development conditions.

Digital Power and Digital Asset Infrastructure

In addition to AI data centers and GPU computing, AZIO AI’s broader platform includes digital power solutions and company-operated digital asset mining infrastructure.

These operations are intended to provide the company with additional opportunities to monetize available computing equipment and power capacity while larger AI data center projects progress through their development and deployment stages.

The company’s diversified model is designed to provide flexibility in allocating infrastructure among AI computing, hosting, enterprise colocation and digital asset workloads based on customer demand and market conditions.

Market Opportunity

The rapid adoption of generative AI, large language models, advanced analytics and AI-enabled enterprise applications is driving significant demand for GPU systems, data center capacity, network infrastructure and electrical power.

AI workloads require substantially greater computing density and power consumption than many traditional data center applications. As enterprises and governments expand their AI capabilities, infrastructure providers must address constraints involving GPU availability, energy capacity, high-speed connectivity, cooling and deployment timelines.

According to IDC figures cited by the company when announcing the completion of its merger, global AI infrastructure-related spending was projected to reach approximately $487 billion in 2026 and exceed $1 trillion by 2029.

AZIO AI is positioning itself within this expanding market through an integrated strategy combining GPU distribution, AI data center development, enterprise connectivity, digital power and customer hosting arrangements.

Growth Strategy

AZIO AI’s growth strategy centers on several principal initiatives:

• Advancing phased development of its planned Texas AI data center platform.
• Establishing the power and fiber infrastructure required to support AI and high-performance computing workloads.
• Securing customer commitments and capacity reservations ahead of major infrastructure deployments.
• Expanding enterprise GPU system and server infrastructure sales.
• Developing recurring revenue opportunities through power hosting, colocation, GPU cloud computing and compute leasing.
• Pursuing strategic technology investments, commercial partnerships and selected infrastructure opportunities in domestic and international markets.
• Using modular construction and staged capital deployment to align infrastructure expenditures with contracted or identifiable customer demand.

Leadership Team

Chris Young serves as Chief Executive Officer and Chairman of AZIO AI Holdings. He has nearly two decades of experience as an entrepreneur, operator, early-stage investor and strategic advisor involved in building and advising technology and consumer-focused businesses. Before completion of the merger, he served as Chief Executive Officer and Chairman of AZIO AI Corporation.

Sir Elgin Tracy serves as Chief Operating Officer of AZIO AI Holdings and is involved in advancing the company’s infrastructure development and operational strategy. His responsibilities include supporting the development of AZIO AI’s Texas platform, enterprise connectivity framework and scalable infrastructure deployment model.

For more information, visit the company’s website at https://www.azioai.ai.

NOTE TO INVESTORS: The latest news and updates relating to AZIO are available in the company’s newsroom at https://ibn.fm/AZIO

• Safe Pro Group has announced that it expects revenue in Q2 2026 to increase over 1,300% year-over-year, to more than 1.3 million.
• This large growth is driven by multiple U.S. Army subcontract awards for Safe Pro’s AI-powered threat detection and mapping software packages.
• Safe Pro has also expanded its AI offering from just the air, to the ground, supporting both drones and autonomous unmanned ground vehicles (“UGVs”).

Safe Pro Group (NASDAQ: SPAI), a tech company that delivers AI-powered security and defense solutions, recently announced that it expects year-over-year revenue to climb dramatically in Q2 2026, based on preliminary and unaudited financial data (https://ibn.fm/rHBLc).

Specifically, Safe Pro expects Q2 2026 revenue to rise to over $1.3 million, which would be 1,300% growth over Q2 2025’s $92,753. This growth is primarily being driven by multiple U.S. Army subcontract awards for its threat detection and mapping software packages.

At the center of Safe Pro’s mission is the Safe Pro Object Threat Detection (“SPOTD”) technology, which allows for the rapid analysis of drone imagery to identify and map potential explosive threats and hazards, improving both mission speed and the safety of those on the ground. Safe Pro’s technology is built on an AI dataset of more than 2.9 million drone images, and it has more than 51,750 confirmed detections across over 37,835 acres of land in Ukraine.

The U.S Army and defense prime contractors continue to select Safe Pro’s software and advanced solutions to map threats, improving situational awareness, and help with planning missions.

In addition, as evidenced by multiple recent rewards, Safe Pro is actively expanding the AI offering to not only run on multiple drone platforms, but also autonomous unmanned ground vehicles (“UGVs”) that the U.S. Army uses.

This expansion also includes the potential use of Safe Pro’s technology by other defense customers, like the U.S. Air Force, as well as for post-conflict reconstruction, rebuilding, and rare earth mineral and agricultural reclamation efforts.

Safe Pro is also increasingly participating in U.S. Army-sponsored operational and technological evaluation events, which opens up the door to additional pathways to potential contracts in the future.

Thanks to having significant cash reserves, no long-term debt, and a growing high-margin revenue stream, Safe Pro is expanding its government business development and contract capture efforts, creating a strong pipeline that’s expected to support continued growth.

Speaking about Safe Pro’s Q2, Dan Erdberg, the Chairman and CEO of Safe Pro, said that “During the second quarter, Safe Pro has continued to capitalize on the growing momentum we have seen in the defense markets for our novel, AI-powered threat detection and mapping technologies. Supported by massive government commitments to the adoption of AI, autonomous vehicles and drones at unprecedented scales, the rapid increase we are seeing in contract award activity provides confidence that we are well positioned to benefit from the broad defense sector demand for our unique AI software technologies.”

About Safe Pro Group Inc. (NASDAQ: SPAI)

Safe Pro Group is a mission-driven tech company that delivers advanced AI-powered security and defense solutions to customers within industries like defense, homeland security, law enforcement, and humanitarian, as well as commercial markets. The core of Safe Pro’s mission is computer vision software technology that can detect, identify and map small objects in drone video and imagery which helps enable safer field operations and offers better situational awareness.

For more information, visit Safe Pro Group’s website at www.SafeProGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SPAI are available in the company’s newsroom at https://ibn.fm/SPAI

• The company will host a stakeholder update call on August 13, 2026, to discuss second-quarter financial results and business initiatives.
• Beeline is using artificial intelligence and automation to shorten mortgage approval and closing timelines while serving both homebuyers and real estate investors.
• Beeline is addressing financing challenges facing Millennials and Generation Z through digital underwriting designed to provide rapid qualification assessments.
• The company is also expanding products aimed at older homeowners seeking to access home equity without refinancing existing low-rate mortgages.
• Q1 2026 results showed revenue and loan originations more than doubling from the prior-year period despite a challenging mortgage market.
• Beeline’s strategy combines mortgage origination, title services and software solutions to create multiple revenue opportunities within residential real estate finance.

Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform offering a quicker and easier path to homeownership, is preparing to provide investors with its latest operating update as the mortgage technology company continues expanding its digital lending platform during a period of ongoing change in the U.S. housing market.

The company announced it will host a stakeholder update call on August 13, 2026, following the release of its second-quarter financial results. Chief Executive Officer Nick Liuzza and Chief Financial Officer Chris Moe are expected to review quarterly performance and discuss the company’s strategic initiatives. (https://ibn.fm/pYl3T).

The upcoming call arrives as mortgage lenders continue adapting to elevated interest rates, affordability constraints and changing borrower demographics that have reshaped residential real estate finance over the past several years. Rather than relying solely on traditional mortgage origination, Beeline has positioned itself as a technology-focused platform that uses artificial intelligence, automation and digital workflows to streamline the lending process.

Headquartered in Providence, Rhode Island, the company operates primarily through its wholly owned subsidiary, Beeline Loans Inc., offering conventional mortgages alongside non-qualified mortgage (Non-QM) products designed for borrowers whose financial profiles may not fit traditional underwriting models. 

Beeline’s strategy centers on reducing friction throughout the mortgage process. The company’s proprietary technology platform incorporates its AI-powered virtual assistant, Bob, together with its production engine known as Hive, allowing borrowers to complete much of the mortgage process digitally. According to the company, loans can close in approximately 14 to 21 days, significantly below traditional industry timelines.

Artificial intelligence also plays an expanding role in the underwriting process. Management says the platform can provide prospective borrowers with an initial qualification assessment in roughly seven to eight minutes while delivering approximately 90% certainty regarding mortgage eligibility. The objective is to give applicants earlier clarity while reducing delays typically associated with manual underwriting.

The company’s technology strategy is particularly relevant for younger borrowers facing persistent barriers to homeownership. According to reporting by National Mortgage Professional, homeownership rates remain relatively low among younger generations, with only 26.1% of Generation Z consumers and 54.9% of Millennials owning homes during 2024. Limited access to mortgage financing continues to be one of the principal challenges confronting first-time buyers.

Beeline is attempting to address that gap by serving not only traditional owner-occupied purchases but also younger consumers seeking to purchase residential investment properties. Management believes many Millennials and Gen Z borrowers increasingly view income-producing real estate as an alternative pathway toward long-term wealth creation, particularly as affordability challenges continue affecting primary housing markets.

This emphasis on investment-property financing distinguishes part of Beeline’s business model from lenders focused primarily on owner-occupied mortgages. The company has continued expanding its portfolio of debt-service coverage ratio loans and bank-statement lending products, which are frequently used by self-employed borrowers and residential property investors who may not qualify under conventional income documentation requirements.

Recent financial results suggest the strategy is gaining traction. During the first quarter of 2026, Beeline reported revenue of $2.7 million, more than doubling from the same period a year earlier. Loan originations increased to $85.6 million across 288 loans, compared with $39.8 million and 128 loans during the prior-year quarter.

Rather than pursuing origination volume alone, management has indicated that profitability and operational efficiency remain priorities while interest rates and housing activity continue to fluctuate. During the company’s first-quarter earnings discussion, executives emphasized expanding lending categories that offer stronger economics while continuing to automate internal processes.

Operational data released by the company also points to improving customer engagement. Management reports that Bob has increased lead-to-lock conversion rates by approximately 8% among online borrowers, while Beeline’s self-service mortgage workflow generated a 131% improvement in application-to-lock pull-through during early deployment.

At the same time, Beeline is broadening its addressable market beyond younger homebuyers. Through BeelineEquity, the company is targeting homeowners who accumulated substantial home equity during years of rising residential property values but are reluctant to refinance mortgages originated during the historically low interest-rate environment of 2020 and 2021.

Management estimates that older homeowners collectively hold approximately $10 trillion in housing equity. BeelineEquity is designed to help homeowners access a portion of that equity without replacing their existing mortgages. Because the platform primarily generates fee income rather than holding loans on its balance sheet, the business provides an additional revenue stream that differs from traditional mortgage lending.

The company is also investing in complementary software capabilities that extend beyond mortgage origination. Beeline maintains a minority interest in MagicBlocks, an artificial intelligence platform supporting sales automation that management says has begun attracting adoption among larger financial institutions.

Beeline is balancing growth with operational discipline while expanding across multiple segments of residential real estate finance. As housing affordability, demographic shifts and digital adoption continue reshaping the mortgage industry, the company’s strategy reflects a broader trend toward technology-enabled lending platforms designed to serve a wider range of borrowers, including younger consumers entering both homeownership and property investing, as well as long-time homeowners seeking new ways to access accumulated housing equity.

For more information, visit the company’s website at www.MakeABeeline.com.

NOTE TO INVESTORS: The latest news and updates relating to BLNE are available in the company’s newsroom at https://ibn.fm/BLNE

• We believe that the decision between debt and equity is one of the most consequential a business owner will ever make, and it is rarely as simple as comparing interest rates to dilution percentages.
• The challenge is that middle-market businesses do not always have clean access to traditional bank financing.
• That diagnostic work is precisely where Market Street Capital’s capital markets practice seeks to add value.

When a founder needs capital to grow, two doors open simultaneously; choosing the wrong one can reshape the company’s future in ways that take years to fully understand. A boutique capital markets and financial advisory firm, Market Street Capital’s team members have spent more than two decades helping established middle-market business owners think clearly about exactly that choice. The company works at the intersection of strategic advisory and sophisticated capital raising, helping founders navigate the debt-versus-equity decision with the kind of institutional expertise that has historically been reserved for much larger companies.

The decision between debt and equity is one of the most consequential a business owner will ever make, and it is rarely as simple as comparing interest rates to dilution percentages. Both paths carry long-term implications for ownership, control, cash flow and strategic flexibility. Getting it right requires understanding not just the mechanics of each instrument, but the moment the business is in, the trajectory it is on and what the capital is intended to accomplish.

At its core, the tradeoff is straightforward. Debt preserves ownership and avoids dilution but creates fixed repayment obligations regardless of business performance. Interest payments are typically tax deductible, which reduces the true cost of borrowing, though founders should consult their own tax advisors, but covenant packages and collateral requirements can constrain operational flexibility.

Equity, by contrast, carries no repayment burden and aligns investors’ returns with the company’s success. However, it permanently reduces the founder’s share of future profits and can introduce new governance dynamics, including board seats and investor influence over major decisions.

According to Carta’s 2025 year-end State of Private Markets report, median dilution across all rounds from seed through Series C fell from approximately 18% to 16% last year, continuing a multiyear downward trend. That said, founders raising equity at any stage should still expect to give up a meaningful share of ownership per round, and those figures reflect a market where investor selectivity has increased alongside deal sizes.

For middle-market founders running established, cash-generating businesses, debt is frequently the more efficient tool. According to PitchBook’s NVCA Venture Monitor, U.S. venture debt volume reached $58.7 billion in 2024, double the volume from 2023, reflecting strong founder demand for growth capital that does not require giving up ownership. Established companies with predictable revenue streams are well positioned to service debt, and doing so allows them to fund acquisitions, expansion or recapitalizations without reducing their share of the upside. According to Phoenix Strategy Group, the after-tax cost of debt financing typically runs between 3 and 8%, while equity investors generally expect returns of 15 to 25%, making debt significantly less expensive for founders who have the cash flow to support it.

The challenge is that middle-market businesses do not always have clean access to traditional bank financing. Post-2008 regulatory requirements pushed banks toward tighter lending standards, particularly for companies without investment-grade credit ratings or substantial hard assets. That structural gap created the conditions for a private credit market that has grown dramatically in response.

According to Morgan Stanley, the private credit market stood at approximately $2 trillion in 2020, grew to $3 trillion entering 2025, and is projected to reach approximately $5 trillion by 2029. Much of that growth is driven by middle-market borrowers who cannot access broadly syndicated loan markets but need flexible, sophisticated financing solutions. For founders in this segment, the universe of debt options has expanded substantially and can include senior debt, unitranche facilities, mezzanine financing, asset-based lending and specialty structures. Each option offers different risk profiles, covenant packages and pricing dynamics.

Mezzanine financing and unitranche structures occupy particularly important roles in middle-market finance, offering borrowers alternatives to traditional bank lending. Mezzanine debt sits between senior debt and equity in the capital stack, providing subordinated capital that fills the gap between what a senior lender will provide and the equity a borrower wants to contribute. Unitranche financing combines senior and subordinated debt into a single credit facility governed by one loan agreement and one blended interest rate, simplifying the borrowing process and often accelerating deal timelines compared to traditional multi-tranche structures.

Both instruments generally provide greater flexibility than conventional bank loans and can reduce the need for an immediate equity raise. These financing solutions are especially common in acquisitions, recapitalizations and growth initiatives where a company requires more capital than traditional senior lenders are willing to provide but seeks to minimize equity dilution.

Equity, however, remains the right answer in specific circumstances. In corporate finance, debt is often best suited for investments with relatively predictable cash flows and identifiable returns, while equity can be a better fit for strategic initiatives that carry greater uncertainty but offer transformational upside. For founders pursuing a genuinely transformational initiative, such as entering a new market, making a significant platform acquisition or funding a new product line that may not generate returns for several years, patient equity capital from aligned investors can provide greater financial flexibility than debt, which requires scheduled principal and interest payments regardless of business performance. Ultimately, the question is not which financing instrument is inherently superior but which one best aligns with a company’s objectives, cash flow profile, and long-term strategy.

That diagnostic work is precisely where Market Street Capital’s capital markets practice adds value. The firm’s Debt Capital Markets and Specialty Lending practice is built specifically for the middle market, connecting clients with senior debt facilities, unitranche and mezzanine structures, asset-based lending and tailored specialty financing through relationships with banks, private credit funds, insurance companies and specialty finance providers.

For founders who determine that equity is the right path, Market Street’s Private Equity Raises practice structures and executes customized raises with access to institutional investors, family offices and private equity sponsors across a large investor network. The company describes its philosophy as ensuring that financing structures support sustainable growth and long-term enterprise value, not just the immediate transaction. For founders confronting the debt-versus-equity question, that kind of independent, structuring-focused advisory can help inform a capital decision that supports the company’s long-term flexibility and options.

Securities transactions offered through Pickwick Capital Partners, LLC, an SEC registered broker dealer member of FINRA and SIPC. Principals of Market Steet Capital are registered representatives of Pickwick.

This communication is for informational purposes only and does not constitute an offer to sell, or the solicitation of an offer to buy, any security, nor an offer to provide any investment, advisory, tax, or legal service. It is not investment, tax, or legal advice, and recipients should consult their own advisors. Market-data statistics are attributed to the third-party sources identified herein, which Market Street Capital believes to be reliable but has not independently verified and does not guarantee. Any statements regarding transaction processes or outcomes are illustrative; results depend on individual facts and market conditions and are not guaranteed, and past or current market conditions may not continue.

For more information, visit www.MarketStreetCP.com.

NOTE TO INVESTORS: The latest news and updates relating to Market Street are available in the company’s newsroom at https://ibn.fm/MarketSt